Observational studyJournal of bone and mineral metabolism2021

Long-term safety and effectiveness of denosumab in Japanese patients with osteoporosis: 3-year post-marketing surveillance study.

Sakae Tanaka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.